[Federal Register Volume 64, Number 209 (Friday, October 29, 1999)] [Notices] [Pages 58417-58418] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 99-28304] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control And Prevention [60Day-00-05] Proposed Data Collections Submitted for Public Comment and Recommendations In compliance with the requirement of Section 3506 (c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Disease Control and Prevention is providing opportunity for public comment on proposed data collection projects. To request more information on the proposed projects or to obtain a copy of the data collection plans and instruments, call the CDC Reports Clearance Officer on (404) 639-7090. Comments are invited on: (a) Whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility; (b) the accuracy of the agency's estimate of the burden of the proposed collection of information; (c) ways to enhance the quality, utility, and clarity of the information to be collected; and (d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques for other forms of information technology. Send comments to Seleda Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, Atlanta, GA 30333. Written comments should be received within 60 days of this notice. Proposed Projects 1. National Telephone Survey of Chronic Fatigue Syndrome--New-- National Center for Infectious Disease (NCID). In 1997, OMB approved the information collection ``Chronic Fatigue Syndrome Surveillance and Related Studies, Prevalence and Incidence of Fatiguing Illness in Sedgwick County, Kansas'' under OMB Number 09200401. Data from this cross-sectional, random-digit-dial survey of prolonged fatiguing illness in Sedgwick County (Wichita), Kansas concluded that prolonged fatigue affects over 6% of the population, the prevalence of chronic fatigue syndrome (CFS) was 0.24%, and that CFS prevalence was highest in white females (0.36%). The proposed study replicates the Sedgwick County study using identical methodology and data collection instruments. Beginning with a random-digit-dial telephone survey to identify fatigued and non- fatigued individuals followed by a detailed telephone interview to obtain additional data on participants' health status. Study objectives are to refine estimates of the magnitude of fatiguing illness and CFS in the United States, with special consideration of under-served populations (children and racial/ethnic minorities), and to determine if the occurrence of fatiguing illness exhibits metropolitan, urban, and rural differences. Prevalence estimates from this proposed cross- sectional study of the U.S. population will be compared to those obtained for Sedgwick County to determine if the Sedgwick County findings can be generalized to the U.S. The total cost to the respondent is $0. ---------------------------------------------------------------------------------------------------------------- Number of Average burden/ Respondents Number of responses/ response (in Total burden respondents respondent hours) hours ---------------------------------------------------------------------------------------------------------------- Screener interview.............................. 51,000 1 0.083 4,233 Telephone interview............................. 12,500 1 0.25 3,125 --------------------------------------------------------------- Total....................................... .............. .............. .............. 7,358 ---------------------------------------------------------------------------------------------------------------- [[Page 58418]] Dated: October 25, 1999. Nancy Cheal, Acting Associate Director for Policy, Planning, and Evaluation, Centers for Disease Control and Prevention (CDC). [FR Doc. 99-28304 Filed 10-28-99; 8:45 am] BILLING CODE 4163-18-P